Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis

Published:2015-04 Issue:2 Volume:64 Page:200-202
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Ito Taisuke,Tatsuno Kazuki,Sakabe Jun-ichi,Fujiyama Toshiharu,Tokura Yoshiki

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference13 articles.

1. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug;Ohmori;Jpn J Pharmacol,2002

2. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs;Yanni;Arch Ophthalmol,1999

3. Olopatadine inhibits TNFalpha release from human conjunctival mast cells;Cook;Ann Allergy Asthma Immunol,2000

4. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells;Tokura;Cell Immunol,2003

5. Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells;Sugita;J Dermatol,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopic dermatitis as Th2 disease revisited;Journal of Cutaneous Immunology and Allergy;2018-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP